Colon Cancer Clinical Trial
Health Behaviors in Patients Who Have Finished Treatment for Stage I, Stage II, or Stage III Colorectal Cancer
Summary
RATIONALE: Gathering information over time from patients who have finished treatment for colorectal cancer may help doctors predict which cancer survivors will improve their physical activity and diet.
PURPOSE: This clinical trial is studying health behaviors in patients who have finished treatment for stage I, stage II, or stage III colorectal cancer.
Full Description
OBJECTIVES:
Primary
To characterize patterns and identify predictors of post-treatment physical activity and dietary changes made by colorectal cancer survivors.
Secondary
To identify the affective and cognitive effects of post-treatment physical activity and dietary changes in these patients.
To identify these patients' preferences regarding diet and physical activity health promotion programs.
OUTLINE: This is a multicenter study.
Patients complete surveys at baseline and at 3 and 6 months. A randomly selected subset of 84 patients also receive an activity monitor to be use at each of the 3 time points. The acceptability of their use is assessed and whether activity levels change across the 3 time points and the extent to which they are convergent with self-reported physical activity are examined.
During each survey, questionnaires are administered to assess the following areas: physical/medical characteristics (self-reported), self-efficacy for physical activity, fruit and vegetable consumption, and dietary fat intake; outcome expectations for physical activity, fruit and vegetable consumption, and dietary fat intake; physical activity and diet behavioral self-regulation; illness representations (causal attributions and controllability of recurrence); perceived risk of colorectal cancer (CRC) recurrence; emotional representations of CRC (cancer-related anxiety and worry about cancer recurrence); healthcare provider recommendations to alter physical activity and dietary intake; social influence from important others; current physical activity and dietary intake; and diet and physical activity program preferences. Patients who received the activity monitor are asked feedback on acceptability of them.
Measures of sociodemographics and disease/treatment characteristics (via medical chart review) are recorded.
Eligibility Criteria
DISEASE CHARACTERISTICS:
Diagnosis of localized or regional colorectal cancer
Stage I, II, or III disease
Completed treatment within the past 6 weeks
No previous diagnosis of colorectal cancer
PATIENT CHARACTERISTICS:
English speaking
No current evidence of neoplastic disease except for nonmelanoma skin cancer
No evidence of severe cognitive impairment
PRIOR CONCURRENT THERAPY:
See Disease Characteristics
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 11 Locations for this study
Camden New Jersey, 08103, United States
Edison New Jersey, 08818, United States
Freehold New Jersey, 07728, United States
Hamilton New Jersey, 08690, United States
Montclair New Jersey, 07042, United States
Morristown New Jersey, 07962, United States
Neptune New Jersey, 07754, United States
New Brunswick New Jersey, 08903, United States
New Brunswick New Jersey, 08903, United States
Princeton New Jersey, 08540, United States
Somerville New Jersey, , United States
Summit New Jersey, 07901, United States
Philadelphia Pennsylvania, , United States
Houston Texas, 77030, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.